Two biotechnology companies hope next year to begin the first clinical trials of therapies derived from human embryonic stem cells.

Geron plans to test a type of neural cell as a treatment for spinal cord injuries, and Advanced Cell Technology wants to plant retinal epithelium cells into the eye to treat retina diseases.